Presented by Dr. K M J Zaki Associate Professor Department of Hepatology SOMC, Sylhet.
What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A...
-
Upload
violet-gaines -
Category
Documents
-
view
213 -
download
0
Transcript of What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A...
![Page 1: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/1.jpg)
What’s New in Poo
SOMC Grand RoundsJanuary 6, 2012
Timothy R. Cassity, Ph. D.Microbiologist
A lighthearted review of the use of human feces for the diagnosis and treatment of human gastrointestinal illnesses from the tainted
viewpoint of a warped Microbiologist
![Page 2: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/2.jpg)
Sorry Winnie, this presentation is about poo, not Pooh
![Page 3: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/3.jpg)
Diagnostic Use of Stool
• Symptomatic patients – GI complaints– Most of related to an infectious etiology
• Asymptomatic patients– Most of screening for potential colon cancers
![Page 4: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/4.jpg)
Symptomatic• Most common symptom is diarrhea
– Lower GI tract
• Dyspepsia, pain, etc– Upper GI tract
![Page 5: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/5.jpg)
What’s not very new
• Routine stool culture– Useful for Salmonella, Shigella, Campylobacter,
and Escherichia coli O157 infections
![Page 6: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/6.jpg)
What’s not very new
• Routine stool culture– Misses some strains of enteropathogenic or
enterotoxigenic E. coli.
![Page 7: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/7.jpg)
Campylobacter EIA
• An enzyme immunoassay is being evaluated at SOMC for the detection of Campylobacter species.– Can be done in < 30 minutes (culture takes 2 – 3
days)– Only need one per patient per illness– Slightly more sensitive than culture
![Page 8: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/8.jpg)
Shiga-Toxin EIA
• An enzyme immunoassay is being evaluated for the detection of shiga toxin-producing strains of E. coli– Requires 16 – 40 hours (culture
takes 2 – 3 days)– Only need one per patient per
illness
![Page 9: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/9.jpg)
Shiga-Toxin EIA
• An enzyme immunoassay is being evaluated for the detection of shiga toxin-producing strains of E. coli– Significantly more sensitive than culture– Detects enterotoxigenic E. coli other than O157
(increases sensitivity about 50%)
![Page 10: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/10.jpg)
What’s not very new
• Routine Ova and Parasite Exam– Very low yield with immunocompetent patients
with no travel history
![Page 11: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/11.jpg)
What’s not very new
• Routine Ova and Parasite Exam– Useful for patients with unexplained anemia
(Strongyloides stercoralis)
![Page 12: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/12.jpg)
What’s not very new
• Routine Ova and Parasite Exam– Ascaris lumbricoides found in rare instances.
![Page 13: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/13.jpg)
SOMC Ova and ParasiteOva & Parasite and Trichrome Stain Results from SOMC
November 1, 2006 through October 31, 2011
Organism/ O & P Result Number (patients) Percentage Clinical Setting
No parasites seen 3649 98.09% Diarrhea/abdominal pain
Blastocystis hominis 31 0.83% Not significant or immunosuppressed?
Giardia lamblia 20 0.54% Diarrhea/abdominal pain
Strongyloides stercoralis 7 0.19% All anemic
Ascaris lumbricoides 0 0% (Pediatric)
Trichuris trichiura 1 0.03% Immigrant (Mexico)
Cryptosporidium species 11 0.30% Diarrhea/abdominal pain
Dientamoeba fragilis 2 0.05% Pediatric
Number of positive patients 72 1.94%
![Page 14: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/14.jpg)
Cryptosporidium/Giardia lamblia DFA
• Direct fluorescent antibody for Giardia lamblia and Cryptosporidium parvum.– Can be done in less than 1 hour– Much more sensitive for finding these organisms,
particularly Cryptosporidium, than traditional ova and parasite exam.
![Page 15: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/15.jpg)
Parasites – Recommended Algorithm
• Order only Giardia lamblia/Cryptosporidium DFA on a single stool specimen on patients over 12 years old unless the patient is anemic, immunosuppressed or has a significant travel history.
![Page 16: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/16.jpg)
Clostridium difficile
![Page 17: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/17.jpg)
Clostridium difficile
• An anaerobic, spore-forming gram positive bacillus, found mostly in the GI tract of mammals.
• Both toxin-producing and non-toxin-producing strains exist– C. difficile culture alone not useful -detects both
types
![Page 18: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/18.jpg)
Clostridium difficile
• Both toxin-producing and non-toxin-producing strains exist– GDH (Glutamate dehydrogenase) detects C.
difficile, but detects both types– GDH can be used to rule out C. difficile, but not
definitively diagnose it.
![Page 19: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/19.jpg)
Clostridium difficile
• Toxigenic culture (Reference Method)– Very sensitive and specific– Culture C. difficile, then test isolate that is
cultured for toxin production or toxin genes– Good academically, not useful clinically– Requires 2 or more days to a negative result, 3
days to positive result
![Page 20: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/20.jpg)
Clostridium difficile
• Up until the last 2 years, most clinical labs used (and >90% still do) C. difficile toxin tests (either toxin A, or toxin A & B combined)
![Page 21: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/21.jpg)
Clostridium difficile
• Present day “state of the art” testing is an amplified DNA probe for a unique genomic region found only in the toxigenic strains.
![Page 22: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/22.jpg)
Clostridium difficile
• Our experience with amplified probe:– Increased sensitivity, 29% better than C. difficile
toxin testing– Correlates well (>95% agreement) with toxigenic
culture, the recognized reference method.
![Page 23: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/23.jpg)
Clostridium difficile
• Potential shortcomings of amplified DNA probes:– Excellent sensitivity – can detect as few as 16 C.
difficile toxin gene copies per 50 microliters of stool– Must correlate with clinical information!
• Presence of C. difficile does not confirm a diagnosis of C. difficile-associated disease.
![Page 24: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/24.jpg)
Clostridium difficile
• Potential shortcomings of amplified DNA probes:– Toxigenic C. difficile is found in many people who
have no symptoms
![Page 25: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/25.jpg)
Clostridium difficile
• Potential shortcomings of amplified DNA probes:– Only method FDA approved for pediatrics, but
remember children under 2 years of age have a high carriage rate, up to 50%.
![Page 26: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/26.jpg)
Clostridium difficile
• Specimen requirements– Specimens only accepted on symptomatic patients
(i.e. diarrhea stool)– Rejected for testing:
• Rattler’s• Formed stool• Stick Test negative (applicator stick stands)
![Page 27: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/27.jpg)
Clostridium difficile
• Specimen requirements– Specimens only accepted on symptomatic patients
(i.e. diarrhea stool)– Acceptable specimens:
• Liquid stool (takes shape of container)• Stick Test Positive (applicator stick falls)
![Page 28: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/28.jpg)
Clostridium difficile
• Specimen requirements– Because sensitivity is >95%, no more than 1
specimen needed• One specimen per patient per week, unless approved
by the Microbiologist or Pathologist
![Page 29: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/29.jpg)
Clostridium difficile
• Specimen requirements– No lab test is indicated for “test of cure.”
Resolution of diarrhea is sufficient.
![Page 30: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/30.jpg)
Clostridium difficile - Treatment
• Adequate treatment involves two dimensions– Eradication of toxin-producing C. difficile– Re-growth of normal bowel flora (particularly
anaerobic flora)
![Page 31: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/31.jpg)
Clostridium difficile - Treatment
• Eradication of toxin-producing C. difficile– Metronidazole not effective for moderate to
severe cases• Kills C. difficile OK, but kills anaerobic GI flora better• Treatment effective initially, but recurrence common
![Page 32: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/32.jpg)
Clostridium difficile - Treatment
• Eradication of toxin-producing C. difficile– Oral vancomycin is the agent of choice– Less toxic to normal GI anaerobes– A taper regimen is preferable – antibiotics kill only
vegetative cells. • Longer coverage is necessary to control germinating
spores• Longer coverage is necessary to allow re-growth of
normal anaerobic GNRs.
![Page 33: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/33.jpg)
Clostridium difficile - Treatment• Fidaxomycin
– Less toxic to normal bowel flora than metronidazole or vancomycin
– Compared to vancomycin 125 mg qid x 10 to 14 days, fidaxomycin had a lower relapse rate.
– Expensive – standard course of therapy approximately $2,800 (wholesale price)
![Page 34: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/34.jpg)
Clostridium difficile - Treatment
• Re-growth of normal bowel flora (particularly anaerobic flora)– Will re-grow eventually if not assaulted– In recurrences more aggressive replacement is
necessary
![Page 35: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/35.jpg)
Clostridium difficile - Treatment
• Re-growth of normal bowel flora (particularly anaerobic flora)– Stool transplant is effective in >90% of cases– Stool transplant involves a lot of testing of donor
stool (which takes several days to complete), and is not aesthetically pleasing
– “Synthetic” stool developed for this purpose
![Page 36: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/36.jpg)
Therapeutic Use of Human Feces
![Page 37: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/37.jpg)
Fecal Transplant
• Used primarily to treat Cl. Difficile associated disease
![Page 38: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/38.jpg)
Fecal Transplant
• How they are performed:
![Page 39: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/39.jpg)
Fecal Transplant• How they are performed:
– Obtain approximately 200 – 300 grams of feces from a close, healthy donor
![Page 40: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/40.jpg)
Fecal Transplant• How they are performed:
– Donor stool is screened for:• Typical and atypical enteric pathogens (stool culture, Y.
enterocolitica, A. hydrophila, and others)• Ova and parasites
– The donor is screened serologically for:• Hepatitis A, B, and C• HIV-1 and HIV-2• Syphilis
![Page 41: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/41.jpg)
Fecal Transplant• How they are performed:
– The recipient is screened for:• Hepatitis A, B, and C• HIV-1 and HIV-2
![Page 42: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/42.jpg)
Fecal Transplant
• How they are performed:– Recipient is treated with oral vancomycin 500 mg
bid for 3 – 4 days (to kill vegetative C. difficile cells)
![Page 43: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/43.jpg)
Fecal Transplant
• How they are performed:– If donor stool is suitable, 200 – 300 grams of
donor feces is blended with 200 – 300 mL of saline to make a slurry
– Donor stool slurry is filtered through a coffee filter to remove particulate matter
![Page 44: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/44.jpg)
Fecal Transplant
• How they are performed:– Donor stool is “implanted” in the recipient via as
nasogastric tube, colonoscope, or enema.
![Page 45: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/45.jpg)
Fecal Transplant
• Stool transplants are effective in >90% of cases– Used only for patients with recurrences
• average duration of C. difficile in study was 11 months– 77 patients studied– 70 (91%) resolved within 6 days of treatment
Reference: Shefchik, C. 2011. Clostridium Difficile Treated By Fecal Microbiota Transplant. Presented
at the American College of Gastroenterology's 76th Annual Scientific Meeting, Oct. 28-Nov. 2 in Washington, D.C
![Page 46: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/46.jpg)
Stools and Asymptomatic Patients
![Page 47: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/47.jpg)
Asymptomatic Patients
• Most tests are methods of screening for GI bleeding or potential colon cancer– Tests that detect GI bleeding– Tests that detect genetic changes associated with
cancer cells
![Page 48: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/48.jpg)
Hemocult (guaiac) Testing
• Traditional test for occult blood– Easy to do– Inexpensive– Sensitivity– Many interfering substances– Dietary changes may be necessary before
collecting stool specimen
![Page 49: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/49.jpg)
Immunochromatographic Testing for Human Hemoglobin (FOBT)
• Traditional test for occult blood– Easy to do, but more expensive than Hemocult– Sensitivity much better (approximately 300 X)
than Hemocult– Few or interfering substances– Dietary changes not necessary before collecting
stool specimen
![Page 50: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/50.jpg)
Comparison of iFOBT and Hemocult
Hemocult (Guaiac Test) Immunochromatographic
Test Method Chemical Immunological
Interpretation Look for blue color after addition of developer
Look for a line – similar to a pregnancy test
Specificity Depends on patients diet >96% for human hemoglobin
Sensitivity ≈50% - Detects 90,000 ng/mL or higher of hemoglobin
>87% - Detects as low as 50 ng/mL of human hemoglobin
Overall Accuracy >97% < 86%
Dietary Restrictions None Several
Samples required One (or two) Three
![Page 51: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/51.jpg)
Cancer Cell DNA Screening
• Cells continually shed from the lining of the colon, including cells from precancerous polyps and cancerous tumors.
• Adenomas and tumors have DNA segments that are different from normal human colonic cells.
![Page 52: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/52.jpg)
Cancer Cell DNA Screening
• DNA “markers” are shed with the cells from abnormal cells– Shedding is continuous– But, multiple markers are needed to achieve high
detection rates– Only 0.01% of DNA found in stool is of human
origin, so a sensitive method is needed to detect the markers (amplified DNA probes)
![Page 53: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/53.jpg)
Cancer Cell DNA Screening
• Fecal DNA tests demonstrate high detection rates of early-stage colon cancer.– Have been shown to be more sensitive than fecal
occult blood tests.
![Page 54: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/54.jpg)
Cancer Cell DNA Screening
• Currently, only 1 test is available– It is not FDA approved
• A number of second generation tests have been developed and undergoing final clinical validation in multicenter studies by the FDA.
![Page 55: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/55.jpg)
Cancer Cell DNA Screening
• Interpretation of results:– Negative result – NO DNA markers common to
colon cancer or precancerous polyps are found.– Positive result - DNA markers common to colon
cancer or precancerous polyps were found Additional evaluation — usually colonoscopy — would be recommended.
![Page 56: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/56.jpg)
Cancer Cell DNA Screening
• Interpretation of results:– False Negative result – These may occur if colon
cancer or polyps do not harbor DNA markers targeted by the stool DNA test, or if markers are present in extremely low amounts.
![Page 57: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/57.jpg)
Cancer Cell DNA Screening
• Interpretation of results:– False Positive result – (Marker +, negative
colonoscopy) - These may occur if colon cancer or polyps do not harbor DNA markers targeted by the stool DNA test, or if markers are present in extremely low amounts.
– Algorithm being developed that may include an upper GI and re-evaluation of DNA markers
![Page 58: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/58.jpg)
Cancer Cell DNA Screening
• Stool DNA tests for colon cancer screening are endorsed by:– American Cancer Society– U.S. Multi-Society Task Force on Colorectal Cancer – American College of Radiology
![Page 59: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/59.jpg)
Cancer Cell DNA Screening
• No stool DNA tests for colon cancer screening have been endorsed by the U.S. Preventive Services Task Force
![Page 60: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/60.jpg)
Cancer Cell DNA Screening
• Medicare does not pay for the test, but some private insurers do
![Page 61: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/61.jpg)
Questions?
![Page 62: What’s New in Poo SOMC Grand Rounds January 6, 2012 Timothy R. Cassity, Ph. D. Microbiologist A lighthearted review of the use of human feces for the diagnosis.](https://reader036.fdocuments.in/reader036/viewer/2022081519/56649db55503460f94aa5fae/html5/thumbnails/62.jpg)